The top global medtech industry dynamics identified by the G-MedTech Research team over the past week, briefly presented in multiple languages.

Canon Medical Systems and Olympus are collaborating in the field of Endoscopic Ultrasound Systems (EUS), with Canon Medical developing the Aplio i800 diagnostic ultrasound system for EUS applications and Olympus responsible for sales and marketing.

Lunit will provide Samsung with two AI-powered chest screening solutions, Lunit INSIGHT CXR and Lunit INSIGHT CXR Triage, to improve the accuracy and speed of chest screening, with an initial focus on the US, Canadian and European markets.

Dexcom officially broke ground on its new state-of-the-art manufacturing facility in Co Galway, Ireland, which will have the capacity to produce millions of real-time continuous glucose monitoring (rtCGM) sensors each year, creating over 1,000 jobs.

Orthofix will distribute MRIguidance‘s BoneMRI™ imaging software with 7D Surgical‘s FLASH™ navigation system in the US, the first radiation-free preoperative imaging and spine surgery navigation solution.

AnX Robotica receives US FDA clearance for expanded indications of its NaviCam Small Bowel (SB) video capsule endoscopy in both adults and children aged 2 years and older, as well as the NaviCam Tether, an accessory for the NaviCam SB capsule designed to aid in visualisation of the oesophagus prior to capsule release into the GI tract.

Abbott receives US FDA approval for expanded MRI labeling for its dorsal root ganglion (DRG) stimulation therapy, the Proclaim™ DRG Neurostimulation System, allowing patients to undergo full-body MRI scans while implanted with the device.

Reflow Medical receives CE Mark certification for the Bare Temporary Spur Stent System for the treatment of de novo or restenotic lesions in the infrapopliteal arteries with a commercially available drug-coated balloon (DCB) to enhance drug absorption.

Bolt Navigation has closed its Series B financing led by Grand Oaks Capital and followed by Impact Capital of New York, to support commercialization of the Bolt Navigation System in the U.S., EU and other markets, clinical studies, and expansion of additional indications.

Suzhou, China-based Eden Technology closes tens of millions of yuan Pre-A financing led by Apricot Capital, for the development and commercialization of new CT tubes.

Xiamen, China-based Manteia Technologies closes RMB 110 million ($15.4 million) Series B Financing. Manteia is committed to innovation in adaptive radiotherapy treatment through intensive research in artificial intelligence, data analysis and advanced algorithms.

en_GBEnglish (UK)